title: Nicotine replacement therapy as a smoking cessation aid among disadvantaged smokers: What answers do we need?
abstract: In Australia and New Zealand, population groups who experience social disadvantage smoke at much higher rates than the general population. As there are limited data specific to these groups regarding the success of nicotine replacement therapy for smoking cessation, this commentary will provide an overview of the relevant international literature supplemented with observational data relevant to the policy contexts in Australia and New Zealand. [Paul C, Wolfenden L, Tzelepis F, Yoong S, Bowman J, Wye P, Sherwood E, Rose S, Wiggers J. Nicotine replacement therapy as a smoking cessation aid among disadvantaged smokers: What answers do we need? Drug Alcohol Rev 2016;35:785-789].
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.
authors.forename: Christine
authors.initials: C
authors.lastname: Paul
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.|Hunter New England Population Health, Newcastle, Australia.
authors.forename: Luke
authors.initials: L
authors.lastname: Wolfenden
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.|Hunter New England Population Health, Newcastle, Australia.
authors.forename: Flora
authors.initials: F
authors.lastname: Tzelepis
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.|Hunter New England Population Health, Newcastle, Australia.
authors.forename: Serene
authors.initials: S
authors.lastname: Yoong
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.
authors.forename: Jenny
authors.initials: J
authors.lastname: Bowman
authors.affiliation: Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.|Hunter New England Population Health, Newcastle, Australia.
authors.forename: Paula
authors.initials: P
authors.lastname: Wye
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.
authors.forename: Emma
authors.initials: E
authors.lastname: Sherwood
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.
authors.forename: Shiho
authors.initials: S
authors.lastname: Rose
authors.affiliation: Priority Research Centre for Health Behaviour, University of Newcastle, Newcastle, Australia.|Hunter Medical Research Institute, HMRI Building, University of Newcastle, Newcastle, Australia.|Hunter New England Population Health, Newcastle, Australia.
authors.forename: John
authors.initials: J
authors.lastname: Wiggers
mesh_terms: D006801:Humans; D009538:Nicotine / Q000627:therapeutic use*; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention / Q000379:methods*; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000188:drug therapy*
chemical_list: D009538:Nicotine
keywords: Australia; New Zealand; nicotinic agonist; population group; smoking cessation